Although discussion on the board regarding the 5 missing

New Post Public Reply Private Reply Replies (2) Message Board
Jake2212
1,006
Although discussion on the board regarding the 5 missing leaders from the Leadership Team has waned, I find this development even more perplexing now than I did last Wednesday. It was then, after the bios were removed the previous night, that Ken inquired of CYDY and was informed that the removal was: "Nothing notable ... just a reformatting of our website." 3 days of trading then ensued with no reformatting or explanation of the status of the 5 missing leaders, an omission that CYDY could not have expected to bolster a sp already under pressure.

In the middle of CLOVER, CYDY's most important clinical trial since CD-12, it seems inconceivable that CYDY would willingly dispense with the services of Bernie and Joseph, whose duties directly involve the operation of CLOVER. Moreover, Dr Pestill is critical to all of CYDY's cancer efforts. So logic suggests that this must be just a simple "reformatting" of the website. But even if a struggling biotech were to decide to spend money tinkering with its website in the middle of a vital clinical trial, why would it remove the bios of 5 very critical officers/employees without the reformatted website being a finished product, ready to install immediately? This seems like website management 101.

Nevertheless, it's very possible, perhaps even likely, that, notwithstanding the unforced error of CYDY providing a 3 day opportunity to Leronlimab naysayers for sp affected mischief, the tempest in a teapot that I have brewed up above will be easily calmed Monday morning with the publication of a reformatted website proudly depicting the 5 missing leaders in a slightly altered manner, just as CYDY informed Ken. If so, fine. But I can also fathom things playing out very differently on Monday or Tuesday morning.

By now, surely you realize that, once again, I am about to engage in blatant speculation, unsupported by material facts, of the tea leaf, bread crumb, and connect the dots variety. So, by all means, return to the main board if this is not your cup to tea. 

So here is my best effort to submit an alternative scenario to the simple, nothing to see here explanation CYDY offered to Ken. What if CYDY management, i.e., our 3 remaining Leaders, has been meeting periodically with 2 or more potential BP partners since the days leading up to the start of CLOVER in late 2025? What if more than 8 months of such periodic discussions with potential partners have each generated agreed upon outlines of what level of unassailable Recist data would support what level of financial terms for a partnership agreement? What if the last enrolled CLOVER patients, enrolled by April 21 (per CYDY PR), took their first post enrollment Recist by June 16 (56 days after April 21)? What if the Creatv and Natera blood tests together with the multiple Recist tumor shrinkage findings for the initial 40 to 50 patients had already created a reliable predictive pattern of how the 1st Resist findings re tumor shrinkage were likely to evolve subsequently to the degree that a potential partner might feel confident enough with only 1 Resist for the last enrolled patients to leapfrog its rival(s) and pull the trigger on an offer compatible with the previously agreed upon partnership terms outline? 

If some version of elements I have set forth above were in play during the partnership meetings Mr Hoffman told us would be occurring at a San Diego biotech conference June 22-24, that would support an hypothesis that a partnership agreement could have been reached there and will be announced soon. Removing the missing 5 from CYDY's website would support this hypothesis --  assuming the partner is taking over CYDY operations as quickly as possible, including CLOVER, as well as the services of the missing 5. 

Clearly, the above hypothesis is not investment advice, and I have all together too much time on my hands. Nonetheless, hoping for good news on Monday or Tuesday.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 121

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 173

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 211

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 210

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 126

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 123

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 175

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 95

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 157

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 203

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading

Top 5 Most Recently Viewed Articles

Breaker’s TruSend™: A Game Changer in Email Marketing

Updated Category News Views 142

Breaker’s TruSend™: A Game Changer in Email Marketing In the fast-evolving world of marketing, email continues to hold its ground as a vital communication tool. Breaker has recognized the challenges marketers face with fragmented tech stacks and has introduced TruSend™, a robust email distribution platform. This innovation streamlines the email marketing process,...

Continue Reading
DigiKey and Qorvo Collaborate to Enhance Global Distribution

Updated Category News Views 151

DigiKey and Qorvo Forge Strategic Distribution Partnership DigiKey, a prominent global distributor known for its vast selection of technical components and automation products, has entered into a vital distribution agreement with Qorvo®, a leader in connectivity and power solutions. This collaboration aims to boost the availability and delivery speed of Qorvo's...

Continue Reading
Lloyds Bank's Financial Insights for 2025: A Comprehensive Review

Updated Category News Views 345

Overview of Lloyds Bank plc's 2025 Half-Year Results Lloyds Bank plc, a prominent player in the financial services sector, has released its half-year results for 2025, demonstrating resilience and strategic agility. As a member of the Lloyds Banking Group, it continues to show its commitment to delivering value to its stakeholders and customers. Key Financial Highlights...

Continue Reading
Advansor's Latest CO2 Enclosure Solutions Revolutionize Climate Control

Updated Category News Views 97

Advansor Introduces a New Range of CO2 Enclosures Advansor, a leading name in climate solutions, has recently unveiled an innovative line of CO2 enclosures tailored for supermarkets, cold storage facilities, and industrial applications. These enclosures are designed to simplify on-site installations and offer flexible options for outdoor placement. This groundbreaking...

Continue Reading
LG Innotek's Revolutionary Automotive AP Module Enhances Mobility

Updated Category News Views 220

LG Innotek's Innovative Entry into Automotive Semiconductor Market LG Innotek has taken a significant step into the automotive semiconductor component market with the launch of its Automotive Application Processor Module (AP Module). This move comes in response to a growing demand for sophisticated automotive technologies, particularly in the realm of Advanced Driver...

Continue Reading